Cell2in, Inc. is founded by outstanding R&D experts in Korea. Our mission is to select and produce high quality cells for more patients in need of stem cell therapeutics. After a series of researches, we have developed the world's first cell quality measurement, and established the as a platform technology.
The cell therapy market is rapidly increasing, but poor-quality cellular therapy products in global market are unmet therapeutic needs of age-related chronic inflammatory degenerative diseases such as asthma, osteoarthritis and idiopathic pulmonary fibrosis.
Cell2In, Inc. aims to solve its inconsistent and low therapeutic effects due to poor cell quality management system.